• Profile
Close

Improvement of survival for non-small cell lung cancer over time

OncoTargets and Therapy Sep 16, 2017

Xia W, et al. - Analysts wanted to detect whether the improved survival seen at high-volume centers applied to the general population and, more importantly, whether the improvement in lung cancer survival was just a consequence of improved screening work. Rather than improved screening work, this study exhibited improvements among patients, in all stages of non-small cell lung cancer (NSCLC) that were deemed attributable to improved therapy and medical care for NSCLC.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay